medigraphic.com
ISSN 1405-1710 (Print)

2011, Number 3

<< Back Next >>

Rev Cent Dermatol Pascua 2011; 20 (3)

Bowen’s disease

Martínez EV, Ramos GA, Valencia ÁM

Language: Spanish
References: 15
Page: 104-109
PDF size: 80.75 Kb.


ABSTRACT

Bowen’s disease actually is considered cancer in situ, it may become epidermoid carcinoma. It requires effective treatment. The best treatment is surgery but there are other alternatives. We report a case of a 27 year old woman who with surgery.


REFERENCES

  1. Cox NH, Eedy DJ, Morton CA. Guidelines for management of BD: 2006; Rev BJD 2007; 156: 11-21.

  2. Kao O, Naoko I, Yasuko F. Bowen’s disease on the sole associated with human papillomavirus type 31. Journal of Dermatology 2010; 37: 689-691.

  3. Ted R, Mandy H, Marian G. Treatment of Bowen’s disease with topical 5% imiquimod cream: Retrospective study. Dermatol Surg 2007; 33: 427-432.

  4. Jason H, Ashley D, Hobart W. Bowen’s disease: A four-year retrospective review of epidemiology and treatment at a University Center. Dermatol Surg 2008; 34: 878-883.

  5. Ashley D, Hobart W. Variations in presentation of squamous cell carcinoma in situ (Bowen’s disease) in immunocompromized patients. J Am Acad Dermatol 2008; 59: 68-71.

  6. Mitsuishi T, Nakatake M, Kaneko T. Evaluation of telomerase activity in non-genital Bowen’s disease. JEADV 2009; 23: 668-672.

  7. Emmanuella G, Wolfram H, Gisela M. Multicentric Bowen disease in linear porokeratosis. EJD 2007; 17: 439-440.

  8. Ozlen S, Mohamed S, Frederick M. Immunohistochemical staining of palisading basal cells in Bowen’s disease and basal involvement in actinic keratosis: Contrasting staining patterns suggest different cells of origin. AJ Dermatopathol 2008; 30: 123-126.

  9. Gilberto M, Alvin L, Adrian L. Therapeutic options for Bowen’s disease. Australasian Journal of Dermatol 2007; 48: 1-10.

  10. Ketty P, Tamara M, Maria C. Imiquimod 5% cream in the treatment of Bowen’s disease and invasive squamous cell carcinoma. J Am Acad Dermatol 2006; 55: 324-327.

  11. Fabrizio F, Antonietta G, Anna Maria C. Pathologic changes after photodynamic therapy for basal cell carcinoma and Bowen disease. Arch Dermatol 2008; 144(2): 186-194.

  12. Calzavara P, Venturini M, Sala R. Methylaminolaevulinate-based photodynamic therapy of Bowen’s disease and squamous cell carcinoma. BJD 2008; 159: 137-144.

  13. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: Update. BJD 2008; 159: 1245-1266.

  14. Jonathan B, Allan O. Amino evulinic acid photodynamic therapy for skin cancers. Dermatol Clin 2007; 25: 5-14.

  15. Yung A, Johnson P. Topical photodynamic therapy for Bowen’s disease of the digit in epidermolysis bullosa. Br J Dermatol 2005; 153: 664-699.




2020     |     www.medigraphic.com